A detailed history of Park Circle CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Park Circle CO holds 2,764 shares of VRTX stock, worth $1.1 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares
2,764
Previous 2,764 -0.0%
Holding current value
$1.1 Million
Previous $1.3 Million 0.77%
% of portfolio
1.17%
Previous 1.31%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024

BUY
$343.0 - $410.68 $948,052 - $1.14 Million
2,764 New
2,764 $1.12 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $102B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Park Circle CO Portfolio

Follow Park Circle CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Circle CO, based on Form 13F filings with the SEC.

News

Stay updated on Park Circle CO with notifications on news.